Apyx Medical Corp
APYX · XNASCIK 719135fmd_04WF5G9A5VSCBCS7V36KPEB2GBManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 9 | 10 | 17 | 28 | 28 | 49 | 45 | 52 | 48 | 53 |
| Cost of revenue | 4 | 3 | 6 | 9 | 10 | 15 | 15 | 19 | 19 | 20 |
| Net interest income | (0) | (0) | – | – | – | – | – | – | – | – |
| Gross profit | 5 | 7 | 11 | 19 | 18 | 34 | 29 | 34 | 29 | 33 |
| Realized investment gains (losses) | – | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Research and development | 1 | 2 | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 3 |
| Selling, general and administrative | 6 | 9 | 9 | 14 | 12 | 19 | 20 | 22 | 19 | 16 |
| Total operating expenses | 17 | 21 | 25 | 40 | 38 | 48 | 53 | 54 | 48 | 39 |
| Compensation and benefits | – | – | – | – | – | – | – | 19 | 17 | 14 |
| Operating income | (11) | (14) | (14) | (21) | (20) | (14) | (24) | (17) | (19) | (6) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 6 | 6 |
| Interest and investment income | – | – | – | – | – | – | – | 1 | 2 | 1 |
| Other non-operating income (expense) | (0) | 0 | (0) | 1 | 1 | (0) | 1 | (4) | (4) | (4) |
| Income before taxes | (11) | (14) | (15) | (20) | (19) | (15) | (23) | (21) | (23) | (11) |
| Income tax expense | 0 | (0) | (4) | (0) | (8) | 0 | 0 | (2) | 0 | 0 |
| Net income from continuing operations | (12) | (14) | (11) | (20) | (12) | (15) | (23) | (19) | (24) | (11) |
| Net income | (12) | (5) | 63 | (20) | (12) | (15) | (23) | (19) | (23) | (11) |
| Net income to common shareholders | (4) | (5) | 63 | (20) | – | – | (23) | (19) | (23) | (11) |